Are Bigger Ad Policy Changes Coming After US FDA’s Drug Promotion Office Hit Hard By Layoffs?

 
• By Sue Sutter

The loss of policy analyst, legal, project manager and social scientist positions has experts wondering if the Trump Administration is eyeing a broader effort to limit DTC advertising. The OPDP layoffs are expected to result in delayed reviews of promotional pieces.

Delayed sign
Advisory comments on promotional material submissions may be delayed by the personnel cuts in OPDP. (Shutterstock)

More from Marketing & Advertising

More from Agency Leadership